Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.

Battaglia M, Ahmed S, Anderson MS, Atkinson MA, Becker D, Bingley PJ, Bosi E, Brusko TM, DiMeglio LA, Evans-Molina C, Gitelman SE, Greenbaum CJ, Gottlieb PA, Herold KC, Hessner MJ, Knip M, Jacobsen L, Krischer JP, Long SA, Lundgren M, McKinney EF, Morgan NG, Oram RA, Pastinen T, Peters MC, Petrelli A, Qian X, Redondo MJ, Roep BO, Schatz D, Skibinski D, Peakman M.

Diabetes Care. 2019 Nov 21. pii: dc190880. doi: 10.2337/dc19-0880. [Epub ahead of print]

PMID:
31753960
2.

Thermodynamic analysis of the topologically close packed σ phase in the Co-Cr system.

Wang P, Peters MC, Kattner UR, Choudhary K, Olson GB.

Intermetallics (Barking). 2019;105. doi: 10.1016/j.intermet.2018.11.004.

PMID:
31579354
3.

Efficacy of Proximal Resin Infiltration on Caries Inhibition: Results from a 3-Year Randomized Controlled Clinical Trial.

Peters MC, Hopkins AR Jr, Zhu L, Yu Q.

J Dent Res. 2019 Dec;98(13):1497-1502. doi: 10.1177/0022034519876853. Epub 2019 Sep 16.

PMID:
31526071
4.

Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma.

Li X, Hastie AT, Peters MC, Hawkins GA, Phipatanakul W, Li H, Moore WC, Busse WW, Castro M, Erzurum SC, Gaston B, Israel E, Jarjour NN, Levy BD, Wenzel SE, Meyers DA, Fahy JV, Bleecker ER; National Heart, Lung, and Blood Institute's Severe Asthma Research Program (SARP) Networks.

J Allergy Clin Immunol. 2019 Sep 9. pii: S0091-6749(19)31173-X. doi: 10.1016/j.jaci.2019.08.031. [Epub ahead of print] No abstract available.

PMID:
31513878
5.

Advances in ophthalmic preparation: the role of drug nanocrystals and lipid-based nanosystems.

Peters MCC, Santos Neto ED, Monteiro LM, Yukuyama MN, Machado MGM, de Oliveira IF, Zanin MHA, Löbenberg R, Bou-Chacra N.

J Drug Target. 2019 Sep 12:1-12. doi: 10.1080/1061186X.2019.1663858. [Epub ahead of print]

PMID:
31491352
6.

Airway epithelium-shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling.

Altman MC, Lai Y, Nolin JD, Long S, Chen CC, Piliponsky AM, Altemeier WA, Larmore M, Frevert CW, Mulligan MS, Ziegler SF, Debley JS, Peters MC, Hallstrand TS.

J Clin Invest. 2019 Nov 1;129(11):4979-4991. doi: 10.1172/JCI126402.

7.

Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma.

Lachowicz-Scroggins ME, Dunican EM, Charbit AR, Raymond W, Looney MR, Peters MC, Gordon ED, Woodruff PG, Lefrançais E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, Johansson MW, Jarjour NN, Coverstone AM, Castro M, Hastie AT, Bleecker ER, Fajt ML, Wenzel SE, Israel E, Levy BD, Fahy JV.

Am J Respir Crit Care Med. 2019 May 1;199(9):1076-1085. doi: 10.1164/rccm.201810-1869OC.

PMID:
30888839
8.

Unmet Needs in Severe Asthma Subtyping and Precision Medicine Trials. Bridging Clinical and Patient Perspectives.

Siddiqui S, Denlinger LC, Fowler SJ, Akuthota P, Shaw DE, Heaney LG, Brown L, Castro M, Winders TA, Kraft M, Wagers S, Peters MC, Pavord ID, Walker S, Jarjour NN.

Am J Respir Crit Care Med. 2019 Apr 1;199(7):823-829. doi: 10.1164/rccm.201809-1817PP. No abstract available.

PMID:
30726120
9.

A Transcriptomic Method to Determine Airway Immune Dysfunction in T2-High and T2-Low Asthma.

Peters MC, Ringel L, Dyjack N, Herrin R, Woodruff PG, Rios C, O'Connor B, Fahy JV, Seibold MA.

Am J Respir Crit Care Med. 2019 Feb 15;199(4):465-477. doi: 10.1164/rccm.201807-1291OC.

PMID:
30371106
10.

Resin infiltration: An effective adjunct strategy for managing high caries risk-A within-person randomized controlled clinical trial.

Peters MC, Hopkins AR Jr, Yu Q.

J Dent. 2018 Dec;79:24-30. doi: 10.1016/j.jdent.2018.09.005. Epub 2018 Sep 15.

PMID:
30227152
11.

Characterization of the bacterial community in shower water before and after chlorination.

Peters MCFM, Keuten MGA, Knezev A, van Loosdrecht MCM, Vrouwenvelder JS, Rietveld LC, de Kreuk MK.

J Water Health. 2018 Apr;16(2):233-243. doi: 10.2166/wh.2017.189.

PMID:
29676759
12.

ALX receptor ligands define a biochemical endotype for severe asthma.

Ricklefs I, Barkas I, Duvall MG, Cernadas M, Grossman NL, Israel E, Bleecker ER, Castro M, Erzurum SC, Fahy JV, Gaston BM, Denlinger LC, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Levy BD; National Heart Lung and Blood Institute’s Severe Asthma Research Program- Investigators.

JCI Insight. 2018 Mar 22;3(6). pii: 120932. doi: 10.1172/jci.insight.120932. No abstract available.

13.

Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids.

Peters MC, Kerr S, Dunican EM, Woodruff PG, Fajt ML, Levy BD, Israel E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, Johansson MW, Jarjour NN, Coverstone AM, Castro M, Hastie AT, Bleecker ER, Wenzel SE, Fahy JV; National Heart, Lung and Blood Institute Severe Asthma Research Program 3.

J Allergy Clin Immunol. 2019 Jan;143(1):104-113.e14. doi: 10.1016/j.jaci.2017.12.1009. Epub 2018 Mar 7.

PMID:
29524537
14.

Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction.

Dunican EM, Elicker BM, Gierada DS, Nagle SK, Schiebler ML, Newell JD, Raymond WW, Lachowicz-Scroggins ME, Di Maio S, Hoffman EA, Castro M, Fain SB, Jarjour NN, Israel E, Levy BD, Erzurum SC, Wenzel SE, Meyers DA, Bleecker ER, Phillips BR, Mauger DT, Gordon ED, Woodruff PG, Peters MC, Fahy JV; National Heart Lung and Blood Institute (NHLBI) Severe Asthma Research Program (SARP).

J Clin Invest. 2018 Mar 1;128(3):997-1009. doi: 10.1172/JCI95693. Epub 2018 Feb 5.

15.

Efficacy of Articaine versus Lidocaine in Supplemental Infiltration for Mandibular First versus Second Molars with Irreversible Pulpitis: A Prospective, Randomized, Double-blind Clinical Trial.

Shapiro MR, McDonald NJ, Gardner RJ, Peters MC, Botero TM.

J Endod. 2018 Apr;44(4):523-528. doi: 10.1016/j.joen.2017.10.003. Epub 2018 Feb 1.

PMID:
29397214
16.

A Novel Polyamine-Targeted Therapy for BRAF Mutant Melanoma Tumors.

Peters MC, Minton A, Phanstiel Iv O, Gilmour SK.

Med Sci (Basel). 2018 Jan 5;6(1). pii: E3. doi: 10.3390/medsci6010003.

17.

A novel polyamine blockade therapy activates an anti-tumor immune response.

Alexander ET, Minton A, Peters MC, Phanstiel O 4th, Gilmour SK.

Oncotarget. 2017 Aug 24;8(48):84140-84152. doi: 10.18632/oncotarget.20493. eCollection 2017 Oct 13.

18.

Internet-Based Monitoring in the Severe Asthma Research Program Identifies a Subgroup of Patients With Labile Asthma Control.

Wong-McGrath K, Denlinger LC, Bleecker ER, Castro M, Gaston B, Israel E, Jarjour NN, Mauger DT, Peters S, Phillips BR, Wenzel SE, Fahy JV, Peters MC; National Heart Lung and Blood Institute’s Severe Asthma Research Program-3 Investigators.

Chest. 2018 Feb;153(2):378-386. doi: 10.1016/j.chest.2017.10.017. Epub 2017 Oct 26.

19.

Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age.

Teague WG, Phillips BR, Fahy JV, Wenzel SE, Fitzpatrick AM, Moore WC, Hastie AT, Bleecker ER, Meyers DA, Peters SP, Castro M, Coverstone AM, Bacharier LB, Ly NP, Peters MC, Denlinger LC, Ramratnam S, Sorkness RL, Gaston BM, Erzurum SC, Comhair SAA, Myers RE, Zein J, DeBoer MD, Irani AM, Israel E, Levy B, Cardet JC, Phipatanakul W, Gaffin JM, Holguin F, Fajt ML, Aujla SJ, Mauger DT, Jarjour NN.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):545-554.e4. doi: 10.1016/j.jaip.2017.05.032. Epub 2017 Aug 31.

20.

Natural killer cell-mediated inflammation resolution is disabled in severe asthma.

Duvall MG, Barnig C, Cernadas M, Ricklefs I, Krishnamoorthy N, Grossman NL, Bhakta NR, Fahy JV, Bleecker ER, Castro M, Erzurum SC, Gaston BM, Jarjour NN, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Israel E, Levy BD; National Heart, Lung, and Blood Institute’s Severe Asthma Research Program-3 Investigators.

Sci Immunol. 2017 Mar 10;2(9). pii: eaam5446. doi: 10.1126/sciimmunol.aam5446.

21.

ALX receptor ligands define a biochemical endotype for severe asthma.

Ricklefs I, Barkas I, Duvall MG, Cernadas M, Grossman NL, Israel E, Bleecker ER, Castro M, Erzurum SC, Fahy JV, Gaston BM, Denlinger LC, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Levy BD; National Heart Lung and Blood Institute’s Severe Asthma Research Program-3 Investigators.

JCI Insight. 2017 Jul 20;2(14). pii: 93534. doi: 10.1172/jci.insight.93534. eCollection 2017 Jul 20. Erratum in: JCI Insight. 2018 Mar 22;3(6):.

22.
23.

CRISPR-Cas and Contact-Dependent Secretion Systems Present on Excisable Pathogenicity Islands with Conserved Recombination Modules.

Carpenter MR, Kalburge SS, Borowski JD, Peters MC, Colwell RR, Boyd EF.

J Bacteriol. 2017 Apr 25;199(10). pii: e00842-16. doi: 10.1128/JB.00842-16. Print 2017 May 15.

24.

Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment.

Alexander ET, Minton AR, Peters MC, van Ryn J, Gilmour SK.

Oncotarget. 2016 Dec 20;7(51):85291-85305. doi: 10.18632/oncotarget.13300.

25.

IL1RL1 asthma risk variants regulate airway type 2 inflammation.

Gordon ED, Palandra J, Wesolowska-Andersen A, Ringel L, Rios CL, Lachowicz-Scroggins ME, Sharp LZ, Everman JL, MacLeod HJ, Lee JW, Mason RJ, Matthay MA, Sheldon RT, Peters MC, Nocka KH, Fahy JV, Seibold MA.

JCI Insight. 2016 Sep 8;1(14):e87871. doi: 10.1172/jci.insight.87871.

26.

Biomarkers of Airway Type-2 Inflammation and Integrating Complex Phenotypes to Endotypes in Asthma.

Peters MC, Nguyen ML, Dunican EM.

Curr Allergy Asthma Rep. 2016 Oct;16(10):71. doi: 10.1007/s11882-016-0651-4. Review.

PMID:
27613654
27.

Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.

Denlinger LC, Phillips BR, Ramratnam S, Ross K, Bhakta NR, Cardet JC, Castro M, Peters SP, Phipatanakul W, Aujla S, Bacharier LB, Bleecker ER, Comhair SA, Coverstone A, DeBoer M, Erzurum SC, Fain SB, Fajt M, Fitzpatrick AM, Gaffin J, Gaston B, Hastie AT, Hawkins GA, Holguin F, Irani AM, Israel E, Levy BD, Ly N, Meyers DA, Moore WC, Myers R, Opina MT, Peters MC, Schiebler ML, Sorkness RL, Teague WG, Wenzel SE, Woodruff PG, Mauger DT, Fahy JV, Jarjour NN; National Heart, Lung, and Blood Institute’s Severe Asthma Research Program-3 Investigators.

Am J Respir Crit Care Med. 2017 Feb 1;195(3):302-313. doi: 10.1164/rccm.201602-0419OC. Erratum in: Am J Respir Crit Care Med. 2018 Apr 1;197(7):971.

28.

Metabolic consequences of obesity as an "outside in" mechanism of disease severity in asthma.

Peters MC, Fahy JV.

Eur Respir J. 2016 Aug;48(2):291-3. doi: 10.1183/13993003.01132-2016. No abstract available.

29.

Alternative splicing of interleukin-33 and type 2 inflammation in asthma.

Gordon ED, Simpson LJ, Rios CL, Ringel L, Lachowicz-Scroggins ME, Peters MC, Wesolowska-Andersen A, Gonzalez JR, MacLeod HJ, Christian LS, Yuan S, Barry L, Woodruff PG, Ansel KM, Nocka K, Seibold MA, Fahy JV.

Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):8765-70. doi: 10.1073/pnas.1601914113. Epub 2016 Jul 18.

30.

Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts.

Peters MC, McGrath KW, Hawkins GA, Hastie AT, Levy BD, Israel E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, Johansson MW, Jarjour NN, Coverstone AM, Castro M, Holguin F, Wenzel SE, Woodruff PG, Bleecker ER, Fahy JV; National Heart, Lung, and Blood Institute Severe Asthma Research Program.

Lancet Respir Med. 2016 Jul;4(7):574-584. doi: 10.1016/S2213-2600(16)30048-0. Epub 2016 Jun 6. Erratum in: Lancet Respir Med. 2018 Mar;6(3):e10.

31.

Interventions for prevention of herpes simplex labialis (cold sores on the lips).

Chi CC, Wang SH, Delamere FM, Wojnarowska F, Peters MC, Kanjirath PP.

Cochrane Database Syst Rev. 2015 Aug 7;(8):CD010095. doi: 10.1002/14651858.CD010095.pub2. Review.

32.

2014 George M. Hollenback memorial prize for research.

Peters MC.

Oper Dent. 2015 Jan-Feb;40(1):2-3. doi: 10.2341/1559-2863-40.1.2. No abstract available.

PMID:
25615636
33.

Monitoring of sound and carious surfaces under sealants over 44 months.

Fontana M, Platt JA, Eckert GJ, González-Cabezas C, Yoder K, Zero DT, Ando M, Soto-Rojas AE, Peters MC.

J Dent Res. 2014 Nov;93(11):1070-5. doi: 10.1177/0022034514551753. Epub 2014 Sep 23.

34.

Efficacy of articaine versus lidocaine as a supplemental buccal infiltration in mandibular molars with irreversible pulpitis: a prospective, randomized, double-blind study.

Rogers BS, Botero TM, McDonald NJ, Gardner RJ, Peters MC.

J Endod. 2014 Jun;40(6):753-8. doi: 10.1016/j.joen.2013.12.022. Epub 2014 Feb 8.

PMID:
24862701
35.

Intelectin-1 is a prominent protein constituent of pathologic mucus associated with eosinophilic airway inflammation in asthma.

Kerr SC, Carrington SD, Oscarson S, Gallagher ME, Solon M, Yuan S, Ahn JN, Dougherty RH, Finkbeiner WE, Peters MC, Fahy JV.

Am J Respir Crit Care Med. 2014 Apr 15;189(8):1005-7. doi: 10.1164/rccm.201312-2220LE. No abstract available.

36.

Quantification of continual anthropogenic pollutants released in swimming pools.

Keuten MG, Peters MC, Daanen HA, de Kreuk MK, Rietveld LC, van Dijk JC.

Water Res. 2014 Apr 15;53:259-70. doi: 10.1016/j.watres.2014.01.027. Epub 2014 Jan 23.

PMID:
24530546
37.

Students' clinical learning in an emerging dental school: an investigation in international collaboration between Michigan and Ghana.

Peters MC, Adu-Ababio F, Jarrett-Ananaba NP, Johnson LA.

J Dent Educ. 2013 Dec;77(12):1653-61.

38.

Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma.

Peters MC, Mekonnen ZK, Yuan S, Bhakta NR, Woodruff PG, Fahy JV.

J Allergy Clin Immunol. 2014 Feb;133(2):388-94. doi: 10.1016/j.jaci.2013.07.036. Epub 2013 Sep 24.

39.

Type 2 immune responses in obese individuals with asthma.

Peters MC, Fahy JV.

Am J Respir Crit Care Med. 2013 Sep 15;188(6):633-4. doi: 10.1164/rccm.201307-1360ED. No abstract available.

PMID:
24032378
40.

Assessment of restorative treatment of patients with amelogenesis imperfecta.

Chen CF, Hu JC, Estrella MR, Peters MC, Bresciani E.

Pediatr Dent. 2013 Jul-Aug;35(4):337-42.

41.

Treatment considerations for patient with Amelogenesis Imperfecta: a review.

Chen CF, Hu JC, Bresciani E, Peters MC, Estrella MR.

Braz Dent Sci. 2013;16(4):7-18.

42.

Minimal intervention dentistry for managing dental caries - a review: report of a FDI task group.

Frencken JE, Peters MC, Manton DJ, Leal SC, Gordan VV, Eden E.

Int Dent J. 2012 Oct;62(5):223-43. doi: 10.1111/idj.12007. Review.

43.

Incidence of caries lesions among patients treated with comprehensive orthodontics.

Richter AE, Arruda AO, Peters MC, Sohn W.

Am J Orthod Dentofacial Orthop. 2011 May;139(5):657-64. doi: 10.1016/j.ajodo.2009.06.037.

PMID:
21536209
44.

The pulpal anesthetic efficacy of articaine versus lidocaine in dentistry: a meta-analysis.

Brandt RG, Anderson PF, McDonald NJ, Sohn W, Peters MC.

J Am Dent Assoc. 2011 May;142(5):493-504.

PMID:
21531931
45.

A qualitative examination of patient awareness and understanding of type 2 diabetes and oral health care needs.

Valerio MA, Kanjirath PP, Klausner CP, Peters MC.

Diabetes Res Clin Pract. 2011 Aug;93(2):159-165. doi: 10.1016/j.diabres.2011.03.034. Epub 2011 Apr 22.

PMID:
21514966
46.

In-vitro evaluation of various treatments to prevent demineralization next to orthodontic brackets.

Behnan SM, Arruda AO, González-Cabezas C, Sohn W, Peters MC.

Am J Orthod Dentofacial Orthop. 2010 Dec;138(6):712.e1-7; discussion 712-3. doi: 10.1016/j.ajodo.2010.05.014.

PMID:
21130326
47.

Clinical reduction of S. mutans in pre-school children using a novel liquorice root extract lollipop: a pilot study.

Peters MC, Tallman JA, Braun TM, Jacobson JJ.

Eur Arch Paediatr Dent. 2010 Dec;11(6):274-8.

PMID:
21108917
48.

New-onset asthma among soldiers serving in Iraq and Afghanistan.

Szema AM, Peters MC, Weissinger KM, Gagliano CA, Chen JJ.

Allergy Asthma Proc. 2010 Sep-Oct;31(5):67-71. doi: 10.2500/aap.2010.31.3383.

PMID:
20929596
49.

In vivo acid etching effect on bacteria within caries-affected dentin.

Gu F, Bresciani E, Barata TJ, Fagundes TC, Navarro MF, Dickens SH, Fenno JC, Peters MC.

Caries Res. 2010;44(5):472-7. doi: 10.1159/000320362. Epub 2010 Sep 23.

50.

Strategies for noninvasive demineralized tissue repair.

Peters MC.

Dent Clin North Am. 2010 Jul;54(3):507-25. doi: 10.1016/j.cden.2010.03.005. Review.

PMID:
20630193

Supplemental Content

Loading ...
Support Center